(Q33402421)

English

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

object named as

Nozomu Fuse

6

0 references

Junichiro Watanabe

object named as

Junichiro Watanabe

4

0 references

2

object named as

Toshihiko Doi

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Takayuki Yoshino

7

object named as

Takayuki Yoshino

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

8

object named as

Atsushi Ohtsu

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

object named as

Narikazu Boku

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kazuhiro Shibayama

10

object named as

Kazuhiro Shibayama

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Takatoshi Takubo

11

object named as

Takatoshi Takubo

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Haruyasu Murakami

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nobuyuki Yamamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Satoru Otani

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Elwyn Loh

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

19 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

407-414

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

IGF-1 receptor inhibitors in clinical trials--early lessons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

Disrupting insulin-like growth factor signaling as a potential cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

Oncogenic kinase signalling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

The insulin-like growth factor-binding protein (IGFBP) superfamily

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

Insulin-like growth factors and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

The IGF-I receptor in cell growth, transformation and apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

The role of the insulin-like growth factor system in human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

14 July 2018

Insulin-like growth factor-1 delays Fas-mediated apoptosis in human neutrophils through the phosphatidylinositol-3 kinase pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1924-9

21 January 2018

High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3428530

31 October 2018

Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22810805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factors and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22810805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00280-012-1924-9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

release_lnqz2z5amjcxtfkdfud2qk3fli

1 reference

https://api.fatcat.wiki/v0/release/lnqz2z5amjcxtfkdfud2qk3fli

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33402421&oldid=2195326223"